Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025)

Dianthus Therapeutics (DNTH) has 4 years of Other Non Operating Income data on record, last reported at -$437000.0 in Q3 2025.

  • For Q3 2025, Other Non Operating Income fell 810.42% year-over-year to -$437000.0; the TTM value through Sep 2025 reached -$538000.0, down 337.4%, while the annual FY2024 figure was -$64000.0, 24.71% up from the prior year.
  • Other Non Operating Income reached -$437000.0 in Q3 2025 per DNTH's latest filing, down from -$30000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $27000.0 in Q4 2024 and bottomed at -$437000.0 in Q3 2025.
  • Average Other Non Operating Income over 4 years is -$76833.3, with a median of -$30500.0 recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: surged 184.38% in 2024, then plummeted 810.42% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at -$208000.0 in 2022, then skyrocketed by 84.62% to -$32000.0 in 2023, then soared by 184.38% to $27000.0 in 2024, then tumbled by 1718.52% to -$437000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were -$437000.0 in Q3 2025, -$30000.0 in Q2 2025, and -$98000.0 in Q1 2025.